Celgene Net Income 2006-2018 | CELG

Celgene annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Celgene net income for the quarter ending December 31, 2018 was $1.073B, a 1424.69% decline year-over-year.
  • Celgene net income for the twelve months ending December 31, 2018 was $4.046B, a 37.62% increase year-over-year.
  • Celgene annual net income for 2018 was $4.046B, a 37.62% increase from 2017.
  • Celgene annual net income for 2017 was $2.94B, a 47.07% increase from 2016.
  • Celgene annual net income for 2016 was $1.999B, a 24.78% increase from 2015.
Celgene Annual Net Income
(Millions of US $)
2018 $4,046
2017 $2,940
2016 $1,999
2015 $1,602
2014 $2,000
2013 $1,450
2012 $1,456
2011 $1,318
2010 $881
2009 $777
2008 $-1,534
2007 $226
2006 $69
2005 $64
Celgene Quarterly Net Income
(Millions of US $)
Q4 2018 $1,073
Q3 2018 $1,082
Q2 2018 $1,045
Q1 2018 $846
Q4 2017 $-81
Q3 2017 $988
Q2 2017 $1,101
Q1 2017 $932
Q4 2016 $429
Q3 2016 $171
Q2 2016 $598
Q1 2016 $801
Q4 2015 $561
Q3 2015 $-34
Q2 2015 $356
Q1 2015 $719
Q4 2014 $614
Q3 2014 $509
Q2 2014 $598
Q1 2014 $280
Q4 2013 $214
Q3 2013 $373
Q2 2013 $478
Q1 2013 $385
Q4 2012 $263
Q3 2012 $424
Q2 2012 $367
Q1 2012 $402
Q4 2011 $410
Q3 2011 $373
Q2 2011 $279
Q1 2011 $256
Q4 2010 $210
Q3 2010 $281
Q2 2010 $155
Q1 2010 $234
Q4 2009 $254
Q3 2009 $217
Q2 2009 $143
Q1 2009 $163
Q4 2008 $-149
Q3 2008 $137
Q2 2008 $120
Q1 2008 $-1,641
Q4 2007 $75
Q3 2007 $39
Q2 2007 $55
Q1 2007 $57
Q4 2006 $23
Q3 2006 $20
Q2 2006 $10
Q1 2006 $16
Q4 2005 $4
Q3 2005 $1
Q2 2005 $11
Q1 2005 $48
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $61.913B $15.281B
Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID, ABRAXANE, OTEZLA, ISTODAX and IDHIFA. The drug candidates in their pipeline are at various stages of preclinical and clinical development. These candidates include their IMiDs compounds, which are a proprietary class of compounds that have certain immunomodulatory and other biologically important properties in addition to their leading oral anti-inflammatory agents and cellular therapies. They believe their commercial stage products and the depth of their product pipeline, provide the catalysts for future growth.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.179B 12.96
Gilead Sciences (GILD) United States $81.339B 10.35
Vertex Pharmaceuticals (VRTX) United States $46.409B 62.17
Illumina (ILMN) United States $45.392B 53.98
Regeneron Pharmaceuticals (REGN) United States $42.814B 19.89
Biogen (BIIB) United States $42.629B 8.26
Alexion Pharmaceuticals (ALXN) United States $29.098B 18.03
Incyte (INCY) United States $18.285B 170.68
BioMarin Pharmaceutical (BMRN) United States $15.706B 0.00
Seattle Genetics (SGEN) United States $11.880B 0.00
Exact Sciences (EXAS) United States $11.193B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.441B 53.86
Alnylam Pharmaceuticals (ALNY) United States $8.981B 0.00
QIAGEN (QGEN) Netherlands $8.890B 29.42
Sarepta Therapeutics (SRPT) United States $8.716B 0.00
Bluebird Bio (BLUE) United States $8.058B 0.00
BeiGene (BGNE) Cayman Islands $7.395B 0.00
Bio-Techne Corp (TECH) United States $7.264B 48.94
Exelixis (EXEL) United States $6.969B 16.24
Guardant Health (GH) United States $6.789B 0.00
Moderna (MRNA) United States $6.251B 0.00
Amarin (AMRN) Ireland $5.654B 0.00
Alkermes (ALKS) Ireland $5.299B 0.00
Galapagos (GLPG) Belgium $5.096B 0.00
Ascendis Pharma (ASND) Denmark $5.005B 0.00
Array BioPharma (ARRY) United States $4.908B 0.00
Horizon Pharma Public (HZNP) Ireland $4.553B 14.67
Spark Therapeutics (ONCE) United States $4.290B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.039B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.755B 0.00
Blueprint Medicines (BPMC) United States $3.465B 0.00
China Biologic Products (CBPO) China $3.434B 21.28
Immunomedics (IMMU) United States $3.332B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.315B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.262B 0.00
Allogene Therapeutics (ALLO) United States $3.104B 0.00
Amicus Therapeutics (FOLD) United States $2.966B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $2.890B 0.00
Global Blood Therapeutics (GBT) United States $2.789B 0.00
Reata Pharmaceuticals (RETA) United States $2.594B 0.00
Repligen (RGEN) United States $2.587B 79.61
Mirati Therapeutics (MRTX) United States $2.583B 0.00
Genomic Health (GHDX) United States $2.560B 65.44
Ligand Pharmaceuticals (LGND) United States $2.553B 19.06
Akcea Therapeutics (AKCA) United States $2.491B 0.00
Emergent Biosolutions (EBS) United States $2.475B 20.65
Myriad Genetics (MYGN) United States $2.425B 24.70
UniQure (QURE) Netherlands $2.387B 0.00
Acceleron Pharma (XLRN) United States $2.283B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.251B 0.00
Halozyme Therapeutics (HALO) United States $2.247B 0.00
MyoKardia (MYOK) United States $2.190B 0.00
Insmed (INSM) United States $2.187B 0.00
Arena Pharmaceuticals (ARNA) United States $2.138B 0.00
REGENXBIO (RGNX) United States $2.105B 21.97
Nabriva Therapeutics AG (NBRV) Ireland $2.098B 0.00
Medicines (MDCO) United States $1.963B 0.00
AnaptysBio (ANAB) United States $1.921B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.861B 0.00
Denali Therapeutics (DNLI) United States $1.853B 0.00
NeoGenomics (NEO) United States $1.774B 144.31
Atara Biotherapeutics (ATRA) United States $1.728B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.691B 0.00
Myovant Sciences (MYOV) United Kingdom $1.643B 0.00
Audentes Therapeutics (BOLD) United States $1.575B 0.00
Allakos (ALLK) United States $1.565B 0.00
Puma Biotechnology (PBYI) United States $1.503B 0.00
WAVE Life Sciences (WVE) Singapore $1.434B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.416B 0.00
Innoviva (INVA) United States $1.389B 3.83
GOSSAMER BIO (GOSS) United States $1.367B 0.00
Aimmune Therapeutics (AIMT) United States $1.336B 0.00
Clovis Oncology (CLVS) United States $1.313B 0.00
Rubius Therapeutics (RUBY) United States $1.289B 0.00
Cambrex (CBM) United States $1.285B 13.84
Momenta Pharmaceuticals (MNTA) United States $1.278B 0.00
ALECTOR INC (ALEC) United States $1.234B 0.00
Apellis Pharmaceuticals (APLS) United States $1.194B 0.00
Lion Biotechnologies (IOVA) United States $1.179B 0.00
Editas Medicine (EDIT) United States $1.110B 0.00
Codexis (CDXS) United States $1.063B 0.00
Fate Therapeutics (FATE) United States $1.049B 0.00
Epizyme (EPZM) United States $1.038B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.030B 0.00
InflaRx (IFRX) Germany $1.023B 0.00
RA PHARMCTL INC (RARX) United States $1.007B 0.00
Coherus BioSciences (CHRS) United States $0.992B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.990B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.979B 0.00
Retrophin (RTRX) United States $0.929B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.926B 37.43
Deciphera Pharmaceuticals (DCPH) United States $0.914B 0.00
Sangamo Therapeutics (SGMO) United States $0.909B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.907B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.887B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.867B 0.00
Athenex (ATNX) United States $0.822B 0.00
Principia Biopharma (PRNB) United States $0.806B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.799B 0.00
Vericel (VCEL) United States $0.796B 0.00
Eidos Therapeutics (EIDX) United States $0.783B 0.00
ANI Pharmaceuticals (ANIP) United States $0.782B 14.31
Inotek Pharmaceuticals (RCKT) United States $0.758B 0.00
Intellia Therapeutics (NTLA) United States $0.731B 0.00
Sorrento Therapeutics (SRNE) United States $0.726B 0.00
Cellectis (CLLS) France $0.724B 0.00
Cara Therapeutics (CARA) United States $0.724B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.711B 0.00
Revance Therapeutics (RVNC) United States $0.681B 0.00
Intra-Cellular Therapies (ITCI) United States $0.664B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.661B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.659B 0.00
Osiris Therapeutics (OSIR) United States $0.657B 0.00
Heska (HSKA) United States $0.635B 56.96
Acorda Therapeutics (ACOR) United States $0.625B 8.10
Magenta Therapeutics (MGTA) United States $0.621B 0.00
Twist Bioscience (TWST) United States $0.617B 0.00
Synthorx (THOR) United States $0.599B 0.00
Viking Therapeutics (VKTX) United States $0.595B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.581B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.581B 0.00
ObsEva SA (OBSV) Switzerland $0.575B 0.00
Kura Oncology (KURA) United States $0.568B 0.00
Zealand Pharma (ZEAL) Denmark $0.551B 6.13
Stemline Therapeutics (STML) United States $0.539B 0.00
G1 THERAPEUTICS (GTHX) United States $0.535B 0.00
Arvinas (ARVN) United States $0.510B 0.00
MeiraGTx Holdings (MGTX) United States $0.501B 0.00
Arcus Biosciences (RCUS) United States $0.498B 0.00
Prothena (PRTA) Ireland $0.490B 0.00
UROGEN PHARMA (URGN) Israel $0.488B 0.00
Scholar Rock Holding (SRRK) United States $0.485B 0.00
Cytokineticsorporated (CYTK) United States $0.480B 0.00
Zymeworks (ZYME) Canada $0.472B 0.00
CytomX Therapeutics (CTMX) United States $0.470B 0.00
Five Prime Therapeutics (FPRX) United States $0.464B 0.00
PDL BioPharma (PDLI) United States $0.460B 10.26
Mesoblast (MESO) Australia $0.457B 0.00
Dynavax Technologies (DVAX) United States $0.454B 0.00
DBV Technologies (DBVT) France $0.454B 0.00
AVROBIO (AVRO) United States $0.436B 0.00
Replimune (REPL) United States $0.435B 0.00
Axsome Therapeutics (AXSM) United States $0.433B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.422B 0.00
Senesco Technologies (ELOX) United States $0.420B 0.00
Anika Therapeutics (ANIK) United States $0.418B 15.82
Achillion Pharmaceuticals (ACHN) United States $0.406B 0.00
MannKind (MNKD) United States $0.399B 0.00
BeyondSpring (BYSI) United States $0.398B 0.00
XBiotech (XBIT) United States $0.394B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.380B 0.00
Agenus (AGEN) United States $0.378B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Solid Biosciences (SLDB) United States $0.363B 0.00
BioDelivery Sciences (BDSI) United States $0.363B 0.00
Krystal Biotech (KRYS) United States $0.361B 0.00
Abeona Therapeutics (ABEO) United States $0.361B 0.00
Inovio Pharmaceuticals (INO) United States $0.353B 0.00
Kadmon Holdings (KDMN) United States $0.352B 0.00
Adverum Biotechnologies (ADVM) United States $0.348B 0.00
UNITY Biotechnology (UBX) $0.343B 0.00
Urovant Sciences (UROV) United States $0.342B 0.00
Albireo Pharma (ALBO) United States $0.342B 0.00
MediciNova (MNOV) United States $0.337B 0.00
STEALTH BIOTHER (MITO) United States $0.335B 0.00
OSMOTICA PHARM (OSMT) United States $0.334B 0.00
Gritstone Oncology (GRTS) United States $0.332B 0.00
AC Immune SA (ACIU) Switzerland $0.322B 0.00
Kezar Life Sciences (KZR) United States $0.322B 0.00
Kindred Biosciences (KIN) United States $0.321B 0.00
Protagonist Therapeutics (PTGX) United States $0.321B 0.00
Geron (GERN) United States $0.315B 0.00
Cellular Biomedicine (CBMG) United States $0.303B 0.00
Syros Pharmaceuticals (SYRS) United States $0.302B 0.00
Aduro Biotech (ADRO) United States $0.293B 0.00
Merus (MRUS) Netherlands $0.292B 0.00
Constellation Pharmaceuticals (CNST) United States $0.290B 0.00
Gamida Cell (GMDA) Israel $0.289B 0.00
Strongbridge Biopharma (SBBP) United States $0.279B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.276B 0.00
Enochian BioSciences (ENOB) United States $0.272B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.268B 0.00
Evelo Biosciences (EVLO) United States $0.256B 0.00
Seres Therapeutics (MCRB) United States $0.255B 0.00
Kala Pharmaceuticals (KALA) United States $0.251B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.248B 0.00
Sutro Biopharma (STRO) United States $0.245B 0.00
Kodiak Sciences (KOD) United States $0.243B 0.00
Avid Bioservices (CDMO) United States $0.241B 0.00
Verastem (VSTM) United States $0.239B 0.00
TOCAGEN INC (TOCA) United States $0.239B 0.00
Novavax (NVAX) United States $0.239B 0.00
Cerecor (CERC) United States $0.238B 0.00
Kamada (KMDA) Israel $0.235B 10.60
ResTORbio (TORC) United States $0.228B 0.00
Spero Therapeutics (SPRO) United States $0.227B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.223B 0.00
Athersys (ATHX) United States $0.223B 0.00
Intec Pharma (NTEC) Israel $0.220B 0.00
ChromaDex (CDXC) United States $0.218B 0.00
Axovant Sciences (AXGT) United Kingdom $0.216B 0.00
LogicBio Therapeutics (LOGC) United States $0.214B 0.00
Mersana Therapeutics (MRSN) United States $0.212B 0.00
Celcuity (CELC) United States $0.209B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.208B 0.00
Proteostasis Therapeutics (PTI) United States $0.208B 0.00
Celyad SA (CYAD) Belgium $0.203B 0.00
Arbutus Biopharma (ABUS) Canada $0.198B 0.00
Synlogic (SYBX) United States $0.193B 0.00
VBI Vaccines (VBIV) United States $0.192B 0.00
OvaScience (MLND) United States $0.190B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.187B 0.00
Compugen (CGEN) Israel $0.186B 0.00
Menlo Therapeutics (MNLO) United States $0.180B 0.00
Liquidia Technologies (LQDA) United States $0.173B 0.00
PHASEBIO PHARMA (PHAS) United States $0.165B 0.00
Cue Biopharma (CUE) United States $0.165B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.158B 0.00
Trevena (TRVN) United States $0.157B 0.00
ADMA Biologics Inc (ADMA) United States $0.153B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.153B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.149B 0.00
Aptinyx (APTX) United States $0.146B 0.00
Anavex Life Sciences (AVXL) United States $0.146B 0.00
Allena Pharmaceuticals (ALNA) United States $0.145B 0.00
BioXcel Therapeutics (BTAI) United States $0.144B 0.00
Eton Pharmaceuticals (ETON) United States $0.137B 0.00
Chiasma (CHMA) United States $0.135B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.134B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.132B 0.00
Unum Therapeutics (UMRX) United States $0.132B 0.00
Cohbar (CWBR) United States $0.132B 0.00
Organovo Holdings (ONVO) United States $0.129B 0.00
Enzo Biochem (ENZ) United States $0.121B 0.00
Equillium (EQ) United States $0.118B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.118B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.117B 0.00
XOMA (XOMA) United States $0.114B 0.00
Pluristem Therapeutics (PSTI) Israel $0.113B 0.00
Fortress Biotech (FBIO) United States $0.105B 0.00
Selecta Biosciences (SELB) United States $0.105B 0.00
Checkpoint Therapeutics (CKPT) United States $0.104B 0.00
Catalyst Biosciences (CBIO) United States $0.102B 0.00
Neothetics (EVFM) United States $0.100B 0.00
Mustang Bio (MBIO) United States $0.100B 0.00
NantKwest (NK) United States $0.100B 0.00
Signal Genetics (MGEN) United States $0.098B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.094B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.092B 0.00
Oncobiologics (OTLK) United States $0.092B 0.00
Aptose Biosciences (APTO) Canada $0.091B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.089B 0.00
Provention Bio (PRVB) United States $0.089B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.088B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.085B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.084B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.084B 0.00
Cocrystal Pharma (COCP) United States $0.084B 93.33
AVEO Pharmaceuticals (AVEO) United States $0.081B 0.00
VTv Therapeutics (VTVT) United States $0.080B 0.00
Orgenesis (ORGS) United States $0.078B 0.00
INMUNE BIO INC (INMB) United States $0.078B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.077B 0.00
Applied Genetic Technologies (AGTC) United States $0.076B 0.00
Idera Pharmaceuticals (IDRA) United States $0.075B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.075B 0.00
Alimera Sciences (ALIM) United States $0.074B 0.00
OVID THERAPEUTC (OVID) United States $0.073B 0.00
NewLink Genetics (NLNK) United States $0.071B 0.00
Cidara Therapeutics (CDTX) United States $0.071B 0.00
Prima BioMed (IMMP) Australia $0.070B 0.00
SESEN BIO, INC (SESN) United States $0.068B 0.00
AEterna Zentaris (AEZS) United States $0.068B 12.94
Proteon Therapeutics (PRTO) United States $0.064B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.063B 0.00
Ophthotech (OPHT) United States $0.063B 0.00
Eyenovia (EYEN) United States $0.062B 0.00
Celldex Therapeutics (CLDX) United States $0.061B 0.00
Zosano Pharma (ZSAN) United States $0.061B 0.00
Vascular Biogenics (VBLT) Israel $0.058B 0.00
Vaccinex (VCNX) United States $0.056B 0.00
Alcobra (ARCT) United States $0.056B 0.00
ScPharmaceuticals (SCPH) United States $0.055B 0.00
VistaGen Therapeutics (VTGN) United States $0.055B 0.00
Clearside Biomedical (CLSD) United States $0.053B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.053B 0.00
ANCHIANO THERAP (ANCN) Israel $0.052B 0.00
Arsanis (XFOR) United States $0.050B 0.00
Bellerophon Therapeutics (BLPH) United States $0.050B 0.00
Evogene (EVGN) Israel $0.049B 0.00
Entera Bio (ENTX) Israel $0.048B 0.00
Bionano Genomics (BNGO) United States $0.048B 0.00
Curis (CRIS) United States $0.047B 0.00
DiaMedica Therapeutics (DMAC) United States $0.047B 0.00
VIVUS (VVUS) United States $0.046B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.045B 0.00
TRACON Pharmaceuticals (TCON) United States $0.044B 0.00
AquaBounty Technologies (AQB) United States $0.043B 0.00
Leap Therapeutics (LPTX) United States $0.042B 0.00
Aptevo Therapeutics (APVO) United States $0.039B 0.00
Celsion (CLSN) United States $0.039B 0.00
AZURRX BIOPHARM (AZRX) United States $0.038B 0.00
Moleculin Biotech (MBRX) United States $0.038B 0.00
Caladrius Biosciences (CLBS) United States $0.036B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.034B 0.00
Advaxis (ADXS) United States $0.033B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
Motif Bio Plc (MTFB) United States $0.033B 0.00
Sophiris Bio (SPHS) United States $0.033B 0.00
OncoSec Medical (ONCS) United States $0.032B 0.00
Adial Pharmaceuticals (ADIL) United States $0.029B 0.00
GTx (GTXI) United States $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.029B 0.00
GENPREX INC (GNPX) United States $0.027B 0.00
Vical (VICL) United States $0.027B 0.00
Galena Biopharma (SLS) United States $0.026B 0.00
CytRx (CYTR) United States $0.025B 0.00
IMMURON LTD (IMRN) Australia $0.025B 0.00
Fibrocell Science Inc (FCSC) United States $0.024B 0.00
Titan Pharmaceuticals (TTNP) United States $0.024B 0.00
Novelion Therapeutics (NVLN) Canada $0.023B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
Benitec Biopharma (BNTC) Australia $0.022B 0.00
Dare Bioscience (DARE) United States $0.019B 0.00
Prana Biotechnology (PRAN) Australia $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
Soligenix (SNGX) United States $0.016B 0.00
Apricus Biosciences (SEEL) United States $0.016B 0.00
RestorGenex (DFFN) United States $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 7.37
Genetic Technologies (GENE) Australia $0.014B 0.00
Alliqua BioMedical (ALQA) United States $0.013B 0.00
Edge Therapeutics (PDSB) United States $0.012B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
Neuralstem (CUR) United States $0.011B 0.00
Pulmatrix (PULM) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Histogenics (HSGX) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Tenax Therapeutics (TENX) United States $0.003B 0.00
HOTH THERAPEUTC (HOTH) United States $0.000B 0.00